ArticleBreast cancer research : BCR2019
Investigating the feasibility of stratified breast cancer screening using a masking risk predictor.
Article in Breast cancer research : BCR, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 14 citations in OpenAlex.
- More than density: validating a mammographic masking prediction model in Dutch breast cancer screening.European radiology · 2025Article
- Clinical Significance of Combined Density and Deep-Learning-Based Texture Analysis for Stratifying the Risk of Short-Term and Long-Term Breast Cancer in Screening.Diagnostics (Basel, Switzerland) · 2024Article
- Lipid exposure activates gene expression changes associated with estrogen receptor negative breast cancer.NPJ breast cancer · 2022Article
- Multiclass Segmentation of Suspicious Findings in Simulated Breast Tomosynthesis Images Using a U-Net.Proceedings of SPIE--the International Society for Optical Engineering · 2022Article
- Identifying Women With Mammographically- Occult Breast Cancer Leveraging GAN-Simulated Mammograms.IEEE transactions on medical imaging · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundWomen with dense breasts face a double risk for breast cancer; they are at a higher risk for development of breast cancer than those with less dense breasts, and there is a greater chance that mammography will miss detection of a cancer in dense breasts due to the masking effect of surrounding fibroglandular tissue. These women may be candidates for supplemental screening. In this study, a masking risk model that was previously developed is tested on a cohort of cancer-free women to assess potential efficiency of stratification.
methodsThree masking risk models based on (1) BI-RADS density, (2) volumetric breast density (VBD), and (3) a combination of VBD and detectability were applied to stratify the mammograms of 1897 cancer-free women. The fraction of cancer-free women whose mammograms were deemed by the algorithm to be masked and who would be considered for supplemental imaging was computed as was the corresponding fraction in a screened population of interval (masked) cancers that would be potentially detected by supplemental imaging.
resultsOf the models tested, the combined VBD/detectability model offered the highest efficiency for stratification to supplemental imaging. It predicted that 725 supplemental screens would be performed per interval cancer potentially detected, at an operating point that allowed detection of 64% of the interval cancers. In comparison, stratification based on the upper two BI-RADS density categories required 1117 supplemental screenings per interval cancer detected to capture 64% of interval cancers.
conclusionThe combined VBD/detectability models perform better than BI-RADS and offer a continuum of operating points, suggesting that this model may be effective in guiding a stratified screening environment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.